124 related articles for article (PubMed ID: 24220580)
1. A meningococcal vaccine for infants.
Med Lett Drugs Ther; 2013 Nov; 55(1429):92. PubMed ID: 24220580
[No Abstract] [Full Text] [Related]
2. A new combination haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants.
Pace D; Snape M; Westcar S; Hamaluba M; Yu LM; Begg N; Wysocki J; Czajka H; Maechler G; Boutriau D; Pollard AJ
Pediatr Infect Dis J; 2007 Nov; 26(11):1057-9. PubMed ID: 17984816
[TBL] [Abstract][Full Text] [Related]
3. [Advances in vaccines and invasive disease in children].
Moraga Llop FA
Rev Esp Quimioter; 2001 Dec; 14(4):319-30. PubMed ID: 11856977
[No Abstract] [Full Text] [Related]
4. Epidemiology of vaccine-preventable invasive diseases in Catalonia in the era of conjugate vaccines.
Ciruela P; Martínez A; Izquierdo C; Hernández S; Broner S; Muñoz-Almagro C; Domínguez À;
Hum Vaccin Immunother; 2013 Mar; 9(3):681-91. PubMed ID: 23303166
[TBL] [Abstract][Full Text] [Related]
5. [Conjugated vaccines].
Swennen B; Sternon J
Rev Med Brux; 2002 Jun; 23(3):165-74. PubMed ID: 12143156
[TBL] [Abstract][Full Text] [Related]
6. Early estimate of the effectiveness of quadrivalent meningococcal conjugate vaccine.
Macneil JR; Cohn AC; Zell ER; Schmink S; Miller E; Clark T; Messonnier NE;
Pediatr Infect Dis J; 2011 Jun; 30(6):451-5. PubMed ID: 21206392
[TBL] [Abstract][Full Text] [Related]
7. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
[TBL] [Abstract][Full Text] [Related]
8. Combined Haemophilus Influenzae type B-Neisseria meningitidis serogroup C vaccine is immunogenic and well tolerated in preterm infants when coadministered with other routinely recommended vaccines.
Omeñaca F; Arístegui J; Tejedor JC; Moreno-Perez D; Ruiz-Contreras J; Merino JM; Muro Brussi M; Sánchez-Tamayo T; Castro Fernandez J; Cabanillas L; Peddiraju K; Mesaros N; Miller JM
Pediatr Infect Dis J; 2011 Nov; 30(11):e216-24. PubMed ID: 21747321
[TBL] [Abstract][Full Text] [Related]
9. Immune response of premature infants to meningococcal serogroup C and combined diphtheria-tetanus toxoids-acellular pertussis-Haemophilus influenzae type b conjugate vaccines.
Slack MH; Schapira D; Thwaites RJ; Burrage M; Southern J; Andrews N; Borrow R; Goldblatt D; Miller E
J Infect Dis; 2001 Dec; 184(12):1617-20. PubMed ID: 11740740
[TBL] [Abstract][Full Text] [Related]
10. Licensure of a meningococcal conjugate vaccine (Menveo) and guidance for use - Advisory Committee on Immunization Practices (ACIP), 2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(9):273. PubMed ID: 20224545
[TBL] [Abstract][Full Text] [Related]
11. A multivalent conjugate vaccine for prevention of meningococcal disease in infants.
Harrison LH
JAMA; 2008 Jan; 299(2):217-9. PubMed ID: 18182606
[No Abstract] [Full Text] [Related]
12. FDA approval for infants of a Haemophilus influenzae type b conjugate and hepatitis B (recombinant) combined vaccine.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Feb; 46(5):107-9. PubMed ID: 9045037
[TBL] [Abstract][Full Text] [Related]
13. Challenges in immunisation against bacterial infection in children.
Trück J; Pollard AJ
Early Hum Dev; 2010 Nov; 86(11):695-701. PubMed ID: 20851537
[TBL] [Abstract][Full Text] [Related]
14. Meningococcal vaccine for infants?
Campos-Outcalt D
J Fam Pract; 2012 Aug; 61(8):482-4. PubMed ID: 22871657
[TBL] [Abstract][Full Text] [Related]
15. From the Centers for Disease Control and Prevention. FDA approval for infants of a Haemophilus influenzae type b conjugate and hepatitis B (recombinant) combined vaccine.
JAMA; 1997 Feb; 277(8):620-1. PubMed ID: 9039867
[No Abstract] [Full Text] [Related]
16. Experience of vaccination against invasive bacterial diseases in Veneto region (north east Italy).
Russo F; Pozza F; Napoletano G; Zanella F; Baldovin T; Lazzari R; Cocchio S; Baldo V
J Prev Med Hyg; 2012 Jun; 53(2):113-5. PubMed ID: 23240172
[TBL] [Abstract][Full Text] [Related]
17. Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae.
Trotter CL; McVernon J; Ramsay ME; Whitney CG; Mulholland EK; Goldblatt D; Hombach J; Kieny MP;
Vaccine; 2008 Aug; 26(35):4434-45. PubMed ID: 18617296
[TBL] [Abstract][Full Text] [Related]
18. Challenges for development of meningococcal vaccines in infants and children.
Deasy A; Read RC
Expert Rev Vaccines; 2011 Mar; 10(3):335-43. PubMed ID: 21434801
[TBL] [Abstract][Full Text] [Related]
19. Invasive bacterial diseases: national surveillance in Italy and vaccination coverage in the Local Health Agency 4 "Chiavarese", Liguria region (Italy).
Trucchi C; Zoppi G
J Prev Med Hyg; 2012 Jun; 53(2):120-4. PubMed ID: 23240174
[TBL] [Abstract][Full Text] [Related]
20. An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS).
National Advisory Committee on Immunization (NACI)
Can Commun Dis Rep; 2009 Apr; 35(ACS-3):1-40. PubMed ID: 19400026
[No Abstract] [Full Text] [Related]
[Next] [New Search]
